↓ Skip to main content

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, October 2020
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis
Published in
Arthritis Research & Therapy, October 2020
DOI 10.1186/s13075-020-02340-7
Pubmed ID
Authors

Christian S. Thudium, Anne C. Bay-Jensen, Suntara Cahya, Ernst R. Dow, Morten A. Karsdal, Alisa E. Koch, Wenling Zhang, Robert J. Benschop

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 22%
Student > Bachelor 6 15%
Other 3 7%
Student > Ph. D. Student 3 7%
Student > Doctoral Student 2 5%
Other 8 20%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 10 24%
Biochemistry, Genetics and Molecular Biology 4 10%
Immunology and Microbiology 3 7%
Agricultural and Biological Sciences 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 9 22%
Unknown 10 24%